Trade Mark Journal No.2026/022 29 May 2026

UK00004387329 14 May 2026 (5)

AIMFELPI

International priority date claimed: 13 May 2026 (United States of America) (99821370)

Class 5: Pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention of organ transplant rejection.

Biogen MA Inc.

Representative: Finnegan Europe LLP